Autoimmunity in Atherosclerosis. The Role of Autoantigens

Overview

Journal Clin Rev Allergy Immunol

Specialty Allergy & Immunology

Date 2000 Jul 25

PMID 10907109

Citations 9

Authors

J George

D Harats

Y Shoenfeld

Affiliations

Soon will be listed here.

Citing Articles

CagA , Not CagA , Infection Impairs Endothelial Function Through Exosomes-Mediated ROS Formation.

Xia X, Zhang L, Wu H, Chen F, Liu X, Xu H Front Cardiovasc Med. 2022; 9:881372.

PMID: 35433874 PMC: 9008404. DOI: 10.3389/fcvm.2022.881372.

Exosome-Transmitted miR-25 Induced by Promotes Vascular Endothelial Cell Injury by Targeting KLF2.

Li N, Liu S, Dong K, Zhang G, Huang J, Wang Z Front Cell Infect Microbiol. 2019; 9:366.

PMID: 31750260 PMC: 6842922. DOI: 10.3389/fcimb.2019.00366.

Advances in immune-modulating therapies to treat atherosclerotic cardiovascular diseases.

Chyu K, Shah P Ther Adv Vaccines. 2014; 2(2):56-66.

PMID: 24757525 PMC: 3991155. DOI: 10.1177/2051013613514327.

Dysregulated CD4+ T cells from SLE-susceptible mice are sufficient to accelerate atherosclerosis in LDLr-/- mice.

Wilhelm A, Rhoads J, Wade N, Major A Ann Rheum Dis. 2014; 74(4):778-85.

PMID: 24395554 PMC: 4083014. DOI: 10.1136/annrheumdis-2013-203759.

Influence of CagA-positive Helicobacter pylori strains on atherosclerotic carotid disease.

Rozankovic P, Lovrencic Huzjan A, cupic H, Bencic I, Basic S, Demarin V J Neurol. 2010; 258(5):753-61.

PMID: 21085982 DOI: 10.1007/s00415-010-5824-9.

References

George J, Afek A, Gilburd B, Levy Y, Blank M, Kopolovic J . Atherosclerosis in LDL-receptor knockout mice is accelerated by immunization with anticardiolipin antibodies. Lupus. 1997; 6(9):723-9. View

Virella G, Virella I, Leman R, Pryor M, Lopes-Virella M . Anti-oxidized low-density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers. Int J Clin Lab Res. 1993; 23(2):95-101. DOI: 10.1007/BF02592290. View

Lindquist S, Craig E . The heat-shock proteins. Annu Rev Genet. 1988; 22:631-77. DOI: 10.1146/annurev.ge.22.120188.003215. View

Xu Q, Dietrich H, Steiner H, Gown A, Schoel B, Mikuz G . Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler Thromb. 1992; 12(7):789-99. DOI: 10.1161/01.atv.12.7.789. View

Karopoulos C, Rowley M, Handley C, Strugnell R . Antibody reactivity to mycobacterial 65 kDa heat shock protein: relevance to autoimmunity. J Autoimmun. 1995; 8(2):235-48. DOI: 10.1006/jaut.1995.0018. View

Heery J, Kozak M, Stafforini D, Jones D, Zimmerman G, McIntyre T . Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells. J Clin Invest. 1995; 96(5):2322-30. PMC: 185883. DOI: 10.1172/JCI118288. View

Cushing S, Berliner J, Valente A, Territo M, Navab M, Parhami F . Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci U S A. 1990; 87(13):5134-8. PMC: 54276. DOI: 10.1073/pnas.87.13.5134. View

Freigang S, Horkko S, Miller E, Witztum J, Palinski W . Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. Arterioscler Thromb Vasc Biol. 1998; 18(12):1972-82. DOI: 10.1161/01.atv.18.12.1972. View

KLIMOV A, Denisenko A, Popov A, Nagornev V, Pleskov V, Vinogradov A . Lipoprotein-antibody immune complexes. Their catabolism and role in foam cell formation. Atherosclerosis. 1985; 58(1-3):1-15. DOI: 10.1016/0021-9150(85)90051-6. View

10.

Cook P, Lip G . Infectious agents and atherosclerotic vascular disease. QJM. 1996; 89(10):727-35. DOI: 10.1093/qjmed/89.10.727. View

11.

Loizou S, Cazabon J, Walport M, Tait D, So A . Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus. Arthritis Rheum. 1997; 40(1):103-8. DOI: 10.1002/art.1780400115. View

12.

Paigen B, Morrow A, Holmes P, Mitchell D, Williams R . Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis. 1987; 68(3):231-40. DOI: 10.1016/0021-9150(87)90202-4. View

13.

McNeil H, Simpson R, Chesterman C, Krilis S . Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A. 1990; 87(11):4120-4. PMC: 54059. DOI: 10.1073/pnas.87.11.4120. View

14.

George J, Harats D, Gilburd B, Levy Y, Langevitz P, Shoenfeld Y . Atherosclerosis-related markers in systemic lupus erythematosus patients: the role of humoral immunity in enhanced atherogenesis. Lupus. 1999; 8(3):220-6. DOI: 10.1191/096120399678847597. View

15.

Plump A, Smith J, Hayek T, Aalto-Setala K, Walsh A, Verstuyft J . Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 1992; 71(2):343-53. DOI: 10.1016/0092-8674(92)90362-g. View

16.

Palinski W, Ord V, Plump A, Breslow J, Steinberg D, Witztum J . ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler Thromb. 1994; 14(4):605-16. DOI: 10.1161/01.atv.14.4.605. View

17.

Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Suzuki T, Sumida T . Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J Immunol. 1992; 148(12):3885-91. View

18.

George J, Harats D, Gilburd B, Afek A, Levy Y, Schneiderman J . Immunolocalization of beta2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression. Circulation. 1999; 99(17):2227-30. DOI: 10.1161/01.cir.99.17.2227. View

19.

Rajavashisth T, Andalibi A, Territo M, Berliner J, Navab M, Fogelman A . Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature. 1990; 344(6263):254-7. DOI: 10.1038/344254a0. View

20.

Tsutsumi A, Matsuura E, Ichikawa K, Fujisaku A, Mukai M, Kobayashi S . Antibodies to beta 2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus. Arthritis Rheum. 1996; 39(9):1466-74. DOI: 10.1002/art.1780390905. View